Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 15.4% during the fourth quarter, Holdings Channel reports. The firm owned 64,478 shares of the pharmacy operator’s stock after selling 11,710 shares during the period. Mackenzie Financial Corp’s holdings in Walgreens Boots Alliance were worth $1,684,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Highlander Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Venturi Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 845 shares during the period. Rocky Mountain Advisers LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $30,000. Finally, Planned Solutions Inc. acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $34,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders bought 13,456 shares of company stock valued at $270,423 over the last quarter. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $18.05 on Wednesday. The business’s 50 day moving average is $20.26 and its two-hundred day moving average is $21.86. Walgreens Boots Alliance, Inc. has a 12-month low of $17.51 and a 12-month high of $35.54. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter in the prior year, the firm earned $1.16 earnings per share. The business’s revenue was up 6.3% compared to the same quarter last year. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on WBA. SVB Leerink cut their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. Deutsche Bank Aktiengesellschaft lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, April 3rd. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Finally, Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.